Research Solutions (RSSS) 10-Q 11 May 15 2015 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Mar. 31, 2015	8-May-15
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3
Entity Registrant Name	Research Solutions, Inc.
Entity Central Index Key	1386301
Current Fiscal Year End Date	-24
Entity Filer Category	Smaller Reporting Company
Trading Symbol	RSSS
Entity Common Stock, Shares Outstanding		18,075,265

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Jun. 30, 2014
Current assets:
Cash and cash equivalents	$1,373,036	$1,884,667
Accounts receivable, net of allowance of $54,358 and $49,467, respectively	5,596,362	3,994,987
Prepaid expenses and other current assets	85,147	83,031
Prepaid royalties	1,093,818	552,689
Current assets of discontinued operations	0	1,481,183
Total current assets	8,148,363	7,996,557
Other assets:
Property and equipment, net of accumulated depreciation of $568,629 and $494,459, respectively	100,313	108,914
Intangible assets, net of accumulated amortization of $513,605 and $430,704, respectively	0	55,235
Deposits and other assets	9,502	9,709
Noncurrent assets of discontinued operations	0	872,212
Total assets	8,258,178	9,042,627
Current liabilities:
Accounts payable and accrued expenses	7,204,077	5,749,694
Other liability	187,907	0
Current liabilities of discontinued operations	0	3,598,444
Total current liabilities	7,391,984	9,348,138
Long term liabilities:
Long term liabilities of discontinued operations	0	113,415
Total liabilities	7,391,984	9,461,553
Commitments and contingencies
Stockholders' equity (deficiency):
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock; $0.001 par value; 100,000,000 shares authorized; 18,075,265 and 17,600,242 shares issued and outstanding, respectively	18,075	17,600
Additional paid-in capital	15,682,991	15,406,033
Accumulated deficit	-14,808,633	-15,858,656
Accumulated other comprehensive income (loss)	-26,239	16,097
Total stockholders' equity (deficiency)	866,194	-418,926
Total liabilities and stockholders' equity (deficiency)	$8,258,178	$9,042,627

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets [Parenthetical] (USD $)	Mar. 31, 2015	Jun. 30, 2014
Accounts receivable, allowance	$54,358	$49,467
Property and equipment, accumulated depreciation	568,629	494,459
Intangible assets, accumulated amortization	$513,605	$430,704
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	18,075,265	17,600,242
Common stock, shares outstanding	18,075,265	17,600,242

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Revenue	$8,835,181	$6,791,278	$24,319,637	$20,791,856
Cost of revenue	7,131,714	5,392,784	19,606,613	16,880,209
Gross profit	1,703,467	1,398,494	4,713,024	3,911,647
Operating expenses:
Selling, general and administrative	1,659,152	1,788,319	4,622,406	4,746,191
Depreciation and amortization	25,005	56,359	157,885	154,680
Total operating expenses	1,684,157	1,844,678	4,780,291	4,900,871
Income (loss) from operations	19,310	-446,184	-67,267	-989,224
Other expenses:
Interest expense	-3,875	-3,000	-11,666	-8,344
Other income (expense)	275	-6,510	898	-12,899
Total other expenses	-3,600	-9,510	-10,768	-21,243
Income (loss) from continuing operations before provision for income taxes	15,710	-455,694	-78,035	-1,010,467
Provision for income taxes	-17,526	-4,060	-24,893	-13,941
Loss from continuing operations	-1,816	-459,754	-102,928	-1,024,408
Discontinued operations:
Loss from discontinued operations	0	-216,579	-395,344	-241,428
Gain from deconsolidation of former French subsidiary	0	0	1,548,295	0
Income (loss) from discontinued operations	0	-216,579	1,152,951	-241,428
Net income (loss)	-1,816	-676,333	1,050,023	-1,265,836
Other comprehensive income (loss):
Foreign currency translation	-962	-468	-7,656	-57,991
Comprehensive income (loss)	($2,778)	($676,801)	$1,042,367	($1,323,827)
Basic income (loss) per common share:
Loss per share from continuing operations	$0	($0.03)	($0.01)	($0.06)
Income (loss) per share from discontinued operations	$0	($0.01)	$0.07	($0.01)
Net income (loss) per share	$0	($0.04)	$0.06	($0.07)
Basic weighted average common shares outstanding	17,457,404	17,392,213	17,440,275	17,176,541
Diluted income (loss) per common share:
Loss per share from continuing operations	$0	($0.03)	($0.01)	($0.06)
Income (loss) per share from discontinued operations	$0	($0.01)	$0.07	($0.01)
Net income (loss) per share	$0	($0.04)	$0.06	($0.07)
Diluted weighted average common shares outstanding	17,457,404	17,392,213	17,893,217	17,176,541

Condensed_Consolidated_Stateme1

Condensed Consolidated Statement of Stockholders' Equity (Deficiency) (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Other Comprehensive Income (Loss) [Member]
Balance at Jun. 30, 2014	($418,926)	$17,600	$15,406,033	($15,858,656)	$16,097
Balance (in shares) at Jun. 30, 2014		17,600,242
Stock-based compensation expense	163,702	0	163,702	0	0
Issuance of restricted common stock to employees	164,336	529	163,807	0	0
Issuance of restricted common stock to employees (in shares)		529,393
Common stock repurchase and retirement	-50,605	-54	-50,551
Common stock repurchase and retirement (in shares)		-54,370
Elimination of cumulative translation adjustment upon deconsolidation of former French subsidiary	-34,680	0	0	0	-34,680
Net income for the period	1,050,023	0	0	1,050,023	0
Foreign currency translation	-7,656	0	0	0	-7,656
Balance at Mar. 31, 2015	$866,194	$18,075	$15,682,991	($14,808,633)	($26,239)
Balance (in shares) at Mar. 31, 2015		18,075,265

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash flow from operating activities:
Net income (loss)	$1,050,023	($1,265,836)
Adjustment to reconcile net income (loss) to net cash used in operating activities of continuing operations:
Loss from discontinued operations	395,344	241,428
Gain from deconsolidation of former French subsidiary	-1,548,295	0
Depreciation and amortization	157,885	154,680
Stock-based compensation expense	163,702	188,380
Vesting of restricted common stock to employees	164,336	78,308
Changes in operating assets and liabilities:
Accounts receivable	-1,601,375	-565,532
Prepaid expenses and other current assets	-2,116	-162,652
Prepaid royalties	-541,129	-202,160
Deposits and other assets	207	14
Accounts payable and accrued expenses	1,454,383	904,667
Other liability	187,907	0
Net cash used in operating activities from continuing operations	-119,128	-628,703
Net cash provided by (used in) operating activities of discontinued operations	-34,503	461,829
Net cash used in operating activities	-153,631	-166,874
Cash flow from investing activities:
Purchase of property and equipment	-67,555	-4,182
Purchase of intangible assets	-27,666	-40,976
Net cash used in investing activities from continuing operations	-95,221	-45,158
Net cash used in investing activities from discontinued operations	0	-30,130
Net cash used in investing activities	-95,221	-75,288
Cash flow from financing activities:
Issuance of shares upon exercise of warrants for cash	0	838,000
Common stock repurchased and retirement	-50,605	0
Net cash provided by (used in) financing activities of continuing operations	-50,605	838,000
Net cash used in financing activities of discontinued operations	-67,515	-409,910
Net cash provided by (used in) financing activities	-118,120	428,090
Effect of exchange rate changes	-144,659	-35,651
Net increase (decrease) in cash and cash equivalents	-511,631	150,277
Cash and cash equivalents, beginning of period	1,884,667	1,306,876
Cash and cash equivalents, end of period	1,373,036	1,457,153
Supplemental disclosures of cash flow information:
Cash paid for income taxes	24,893	13,941
Cash paid for interest	$11,666	$8,344

Organization_Nature_of_Busines

Organization, Nature of Business and Basis of Presentation	9 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
Organization, Nature of Business and Basis of Presentation	Note 1. Organization, Nature of Business and Basis of Presentation
	Organization
	Research Solutions, Inc. (the “Company,” “Research Solutions,” “we,” “us” or “our”) was incorporated in the State of Nevada on November 2, 2006.  On March 4, 2013, we consummated a merger with DYSC Subsidiary Corporation, our wholly-owned subsidiary, pursuant to which we, in connection with such merger, amended our Articles of Incorporation to change our name to Research Solutions, Inc. (formerly Derycz Scientific, Inc.). Research Solutions, Inc. is a publicly traded holding company with two wholly owned subsidiaries: Reprints Desk, Inc., a Delaware corporation (“Reprints Desk”) and Reprints Desk Latin America S. de R.L. de C.V, an entity organized under the laws of Mexico (“Reprints Desk Latin America”).
	On August 18, 2014, the Board of Directors of the Company authorized the immediate disposal of the Company’s former subsidiary Techniques Appliquées aux Arts Graphiques, S.p.A. (“TAAG”), an entity organized under the laws of France, at a reasonable price in relation to its current fair value, and in the event such sale was not consummated by September 10, 2014, that management proceed with an insolvency filing by TAAG under French law.  On September 15, 2014, the French Tribunal de Commerce appointed an Administrator for TAAG following a declaration of insolvency by our legal representative, and on October 6, 2014 TAAG entered into a judicial liquidation procedure. As a result, effective September 15, 2014, the Company relinquished control of TAAG to the Tribunal and TAAG ceased to be our subsidiary and was deconsolidated from our financial statements.
	The Company derecognized the assets, liabilities and other comprehensive income of TAAG with a resulting non-cash gain on deconsolidation of $1,548,295 recorded on the consolidated statements of operations.  In addition, comparative information for prior periods have been restated to segregate the assets, liabilities, revenue, expenses, and cash flows related to TAAG as discontinued operations (see Note 6).
	Nature of Business
	We provide on-demand access to scientific, technical, and medical (“STM”) information for life science companies, academic institutions, and other research-intensive organizations. We provide two types of services to our customers: Article Galaxy, and Reprints and ePrints.
	Article Galaxy
	Article Galaxy, our cloud-based software-as-a-service (“SaaS”) solution, provides our customers with a single source to the universe of published STM content that includes over seventy million existing STM articles and over one million newly published STM articles each year. Article Galaxy allows customers to find and download in digital format STM articles that are critical to their research. In addition, Article Galaxy facilitates customers’ compliance with applicable copyright laws.
	Researchers and regulatory personnel in life science and other research-intensive organizations generally require single copies of published STM journal articles for use in their research activities. They place orders with us for the articles they need and we source and electronically deliver the requested content to them generally in under an hour. This service is known in the industry as single article delivery or document delivery. We also obtain the necessary permissions from the content publisher so that our customer’s use complies with applicable copyright laws. We have arrangements with numerous content publishers that allow us to distribute their content. The majority of these publishers provide us with electronic access to their content, which allows us to electronically deliver single articles to our customers often in a matter of minutes. Even though single article delivery services are charged on a transactional basis, customer order volume tends to be consistent from month to month in part due to consistent orders of larger customers that require the implementation of our services into their work flow, subject to fluctuations due to the addition or loss of customers.
	We deliver the aforementioned services through our Article Galaxy journal article platform (“Article Galaxy”), which consists of proprietary software and Internet-based interfaces that allow customers to initiate orders, manage transactions, obtain reporting, automate authentication, improve seamless connectivity to corporate intranets, and enhance the information resources they already own, or have access to via subscriptions or internal libraries, as well as organize workgroups to collaborate around scientific information.
	As a cloud-based SaaS solution, Article Galaxy is deployed as a single system across our entire customer base. Customers access Article Galaxy securely through online web interfaces and via web service APIs, which enable customers to leverage Article Galaxy features and functionality from within proprietary and other 3rd party software systems. Article Galaxy can also be configured to satisfy a customer’s individual preferences in areas such as user experience, business processes, and spend management. As a SaaS solution, Article Galaxy benefits from efficiencies in scalability, stability and development costs, resulting in significant advantages versus multiple instance or installed desktop software alternatives. We leverage these technical efficiencies to fuel rapid innovation and competitive advantage.
	Reprints and ePrints
	Marketing departments in life science and other research-intensive organizations generally require large quantities of printed copies of published STM journal articles called “Reprints” that are distributed to physicians and at conferences. We obtain the necessary permissions from the content publisher so that our customer’s use complies with applicable copyright laws. The majority of content publishers prints their content in-house and prohibits others from printing their content; however, when not prohibited by the content publisher, we use third parties to print Reprint orders. Electronic copies, called “ePrints”, are also used for distribution through the Internet and other electronic mechanisms. We have developed proprietary ePrint software that increase the efficiency of our customers’ content purchases by transitioning from paper Reprints to electronic ePrints, and by improving compliance with applicable copyright laws and promotional regulations within the life science industry. Reprints and ePrints are charged on a transactional basis and order volume typically fluctuates from month to month based on customer marketing budgets and the existence of STM journal articles that fit customer requirements.
	Principles of Consolidation
	The accompanying financial statements are consolidated and include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Effective September 15, 2014, the Company relinquished control of its former subsidiary TAAG and accordingly, it was deconsolidated from our financial statements.
	Basis of Presentation
	The accompanying condensed consolidated financial statements are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2014 filed with the SEC. The condensed consolidated balance sheet as of June 30, 2014 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including notes, required by GAAP.
	In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to fairly present the Company's financial position and results of operations for the interim periods reflected. Except as noted, all adjustments contained herein are of a normal recurring nature. Results of operations for the fiscal periods presented herein are not necessarily indicative of fiscal year-end results.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.
	These estimates and assumptions include estimates for reserves of uncollectible accounts, analysis of impairments of recorded goodwill and intangibles, accruals for potential liabilities and assumptions made in valuing equity instruments issued for services or acquisitions.
	Concentration of Credit Risk
	Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $250,000 insurance limit. The Company does not anticipate incurring any losses related to these credit risks. The Company extends credit based on an evaluation of the customer's financial condition, generally without collateral. Exposure to losses on receivables is principally dependent on each customer's financial condition. The Company monitors its exposure for credit losses and intends to maintain allowances for anticipated losses, as required.
	Cash denominated in Euros with a US Dollar equivalent of $125,275 and $166,723 at March 31, 2015 and June 30, 2014, respectively, was held by Reprints Desk in accounts at financial institutions located in Europe.
	The following table summarizes revenue concentrations:
		Three Months Ended						Nine Months Ended
		March 31,						March 31,
		2015			2014			2015			2014
	Customer A		*			*			*			13	%
	The following table summarizes vendor concentrations:
		Three Months Ended								Nine Months Ended
		March 31,								March 31,
		2015				2014				2015				2014
	Vendor A		25	%			18	%			19	%			23	%
	Vendor B		10	%			11	%			10	%			11	%
	Vendor C		*				*				*				11	%
	Vendor D		10	%			*				12	%			*
	* Less than 10%
	Revenue Recognition
	The Company’s policy is to recognize revenue when services have been performed, risk of loss and title to the product transfers to the customer, the selling price is fixed or determinable, and collectability is reasonably assured. We generate revenue by providing two types of services to our customers: Article Galaxy, and Reprints and ePrints.
	Article Galaxy
	We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. This service, known in the industry as single article delivery or document delivery, generates nearly all of the revenue attributable to the Article Galaxy journal article platform. We recognize revenue from single article delivery services upon delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
	Reprints and ePrints
	We charge a transactional fee for each Reprint or ePrint order and are responsible for printing and delivery of Reprint orders, and the electronic delivery and, in some cases, the electronic delivery mechanism of ePrint orders. The majority of content publishers prints their content in-house and prohibits others from printing their content; however, when not prohibited by the content publisher, we use third parties to print Reprint orders. We recognize revenue from reprints and ePrints services upon shipment or electronic delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
	Stock-Based Compensation
	The Company periodically issues stock options, warrants and restricted stock to employees and non-employees for services, in capital raising transactions, and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of stock option and warrant awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company estimates the fair value of restricted stock awards to employees and directors using the market price of the Company’s common stock on the date of grant, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company accounts for share-based payments to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates.
	Foreign Currency
	The accompanying consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the discontinued operations of our former French subsidiary are in Euros, and the costs of Reprints Desk Latin America are in Mexican Pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities.
	Gains and losses from foreign currency transactions, which result from a change in exchange rates between the functional currency and the currency in which a foreign currency transaction is denominated, are included in selling, general and administrative expenses and amounted to $57,647 and $94,118, for the three and nine months ended March 31, 2015, respectively.
	The following table summarizes the exchange rates used:
		Nine Months Ended						Year Ended
		March 31,						June 30,
		2015			2014			2014			2013
	Period end Euro : US Dollar exchange rate		1.09			1.38			1.36			1.3
	Average period Euro : US Dollar exchange rate		1.24			1.35			1.36			1.29
	Period end Mexican Peso : US Dollar exchange rate		0.07			0.08			0.08			0.08
	Average period Mexican Peso : US Dollar exchange rate		0.07			0.08			0.08			0.08
	Net Income (Loss) Per Share
	Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive. At March 31, 2015 potentially dilutive securities include options to acquire 1,978,391 shares of common stock and warrants to acquire 305,000 shares of common stock.  At March 31, 2014 potentially dilutive securities include options to acquire 1,885,437 shares of common stock and warrants to acquire 904,998 shares of common stock. The dilutive effect of potentially dilutive securities is reflected in diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the reporting period.
	For the nine months ended March 31, 2015, the calculation of diluted earnings per share includes stock options, warrants, and unvested restricted common stock, calculated under the treasury method. Basic and diluted net loss per common share is the same for all periods presented with a net loss because all stock options, warrants, and unvested restricted common stock are anti-dilutive.
	The calculation of basic and diluted net income (loss) per share is presented below:
		Three Months Ended						Nine Months Ended
		March 31,						March 31,
		2015			2014			2015			2014
	Numerator:
	Loss from continuing operations	$	-1,816		$	-459,754		$	-102,928		$	-1,024,408
	Income (loss) from discontinued operations		-			-216,579			1,152,951			-241,428
	Net income (loss)	$	-1,816		$	-676,333		$	1,050,023		$	-1,265,836
	Denominator:
	Weighted average shares outstanding (basic)		17,457,404			17,392,213			17,440,275			17,176,541
	Effect of dilutive unvested restricted common stock		-			-			449,212			-
	Effect of dilutive stock options and warrants		-			-			3,730			-
	Weighted average shares outstanding (diluted)		17,457,404			17,392,213			17,893,217			17,176,541
	Income (loss) per share from continuing operations:
	Basic	$	-		$	-0.03		$	-0.01		$	-0.06
	Diluted	$	-		$	-0.03		$	-0.01		$	-0.06
	Income (loss) per share from discontinued operations:
	Basic	$	-		$	-0.01		$	0.07		$	-0.01
	Diluted	$	-		$	-0.01		$	0.07		$	-0.01
	Net income (loss) per share:
	Basic	$	-		$	-0.04		$	0.06		$	-0.07
Diluted	$	-		$	-0.04		$	0.06		$	-0.07
Recently Issued Accounting Pronouncements
In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 will eliminate transaction- and industry-specific revenue recognition guidance under current U.S. GAAP and replace it with a principle based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for reporting periods beginning after December 15, 2016, and early adoption is not permitted. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. Management is currently assessing the impact the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.
In August 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued.  An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern.  The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. The Company is currently evaluating the impact the adoption of ASU 2014-15 on the Company’s financial statement presentation and disclosures.
In January 2015, the FASB issued Accounting Standards Update (ASU) No. 2015-01 (Subtopic 225-20) - Income Statement - Extraordinary and Unusual Items. ASU 2015-01 eliminates the concept of an extraordinary item from GAAP. As a result, an entity will no longer be required to segregate extraordinary items from the results of ordinary operations, to separately present an extraordinary item on its income statement, net of tax, after income from continuing operations or to disclose income taxes and earnings-per-share data applicable to an extraordinary item. However, ASU 2015-01 will still retain the presentation and disclosure guidance for items that are unusual in nature and occur infrequently. ASU 2015-01 is effective for periods beginning after December 15, 2015. The adoption of ASU 2015-01 is not expected to have a material effect on the Company’s consolidated financial statements. Early adoption is permitted.
In February, 2015, the FASB issued Accounting Standards Update (ASU) No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis. ASU 2015-02 provides guidance on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities such as limited partnerships, limited liability corporations, and securitization structures (collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). ASU 2015-02 is effective for periods beginning after December 15, 2015. The adoption of ASU 2015-02 is not expected to have a material effect on the Company’s consolidated financial statements. Early adoption is permitted.
In April 2015, the FASB issued an accounting ASU 2015-5,  Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-4)  which provides guidance regarding whether a cloud computing arrangement includes a software license.   If a cloud computing arrangement includes a software license, then the entity should account for the software license element of the arrangement consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the entity should account for the arrangement as a service contract. The guidance will not change GAAP for an entity’s accounting for service contracts. This pronouncement is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2015.  Early adoption is permitted.  The Company is currently evaluating the impact the adoption of ASU 2015-03 on the Company’s financial statements and disclosures.
Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Line_of_Credit

Line of Credit	9 Months Ended
	Mar. 31, 2015
Line Of Credit Facility [Abstract]
Line of Credit	Note 3. Line of Credit
	The Company entered into a Loan and Security Agreement with Silicon Valley Bank (“SVB”) on July 23, 2010, which, as amended, provides for a revolving line of credit for the lesser of $4,000,000, or 80% of eligible accounts receivable.  The line of credit matures on October 31, 2015, and is subject to certain financial and performance covenants with which we were in compliance as of March 31, 2015. Financial covenants include maintaining a ratio of quick assets to current liabilities of at least 0.8 to 1.0, and maintaining tangible net worth of $500,000, plus 50% of net income for the fiscal quarter ended from and after December 31, 2013, plus 50% of the dollar value of equity issuances after October 1, 2013 (reduced to 40% of the dollar value of equity issuances in connection with the exercise of warrants in November 2013) and the principal amount of subordinated debt. The line of credit bears interest at the prime rate plus 2.5% for periods in which the Company maintains an account balance with SVB (less all indebtedness owed to SVB) of at least $800,000 at all times during the prior calendar month (the “Streamline Period”), and at the prime rate plus 5.25% when a Streamline Period is not in effect. The interest rate on the line of credit was 5.75% as of March 31, 2015. The line of credit is secured by the Company’s consolidated assets.
	There were no outstanding borrowings under the line as of March 31, 2015 and June 30, 2014, respectively.  As of March 31, 2015 and June 30, 2014, approximately $2,560,000 and $2,185,000, respectively, of available credit was unused under the line of credit.

Stockholders_Equity

Stockholders' Equity	9 Months Ended
	Mar. 31, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Note 4. Stockholders’ Equity
	Stock Options
	In December 2007, we established the 2007 Equity Compensation Plan (the “Plan”). The Plan was approved by our board of directors and stockholders. The purpose of the Plan is to grant stock and options to purchase our common stock to our employees, directors and key consultants. On November 21, 2014, the maximum number of shares of common stock that may be issued pursuant to awards granted under the Plan increased from 3,000,000 to 5,000,000, as approved by our board of directors and stockholders. Cancelled and forfeited stock options and stock awards may again become available for grant under the Plan. There were 2,164,914 shares available for grant under the Plan as of March 31, 2015. All stock option grants are made under the 2007 Equity Compensation Plan.
	The majority of awards issued under the Plan vest immediately or over three years, with a one year cliff vesting period, and have a term of ten years. Stock-based compensation cost is measured at the grant date, based on the fair value of the awards that are ultimately expected to vest, and recognized on a straight-line basis over the requisite service period, which is generally the vesting period.
	The following table summarizes vested and unvested stock option activity:
			All Options						Vested Options					Unvested Options
			Shares			Weighted			Shares			Weighted		Shares		Weighted
						Average						Average				Average
						Exercise						Exercise				Exercise
						Price						Price				Price
	Outstanding at June 30, 2014			1,888,851			1.27			1,526,130			1.21		362,721		1.53
	Granted			89,540			0.82			15,000			0.77		74,540		0.83
	Options vesting			-			-			189,607			1.53		-189,607		1.53
	Exercised			-			-			-			-		-		-
	Forfeited/Cancelled			-			-			-			-		-		-
	Outstanding at March 31, 2015			1,978,391		$	1.25			1,730,737		$	1.24		247,654	$	1.32
	The weighted average remaining contractual life of all options outstanding as of March 31, 2015 was 5.9 years. The remaining contractual life for options vested and exercisable at March 31, 2015 was 6.0 years. Furthermore, the aggregate intrinsic value of all options outstanding as of March 31, 2015 was $60,745, and the aggregate intrinsic value of options vested and exercisable at March 31, 2015 was $43,140, in each case based on the fair value of the Company’s common stock on March 31, 2015. The total fair value of options vested during the nine months ended March 31, 2015 was $163,702 and is included in selling, general and administrative expenses in the accompanying statement of operations.  As of March 31, 2015, the amount of unvested compensation related to these options was $201,912 which will be recorded as an expense in future periods as the options vest.
	Additional information regarding stock options outstanding and exercisable as of March 31, 2015 is as follows:
	Option Exercise Price			Options Outstanding			Remaining			Options Exercisable
							Contractual
							Life (in years)
	$	0.65			6,150			9.61			-
		0.77			59,500			9.39			15,000
		1			370,890			3.89			346,998
		1.02			287,000			5.33			287,000
		1.07			53,898			7.55			50,565
		1.15			278,000			7.86			246,000
		1.2			31,414			9.14			-
		1.25			32,000			7.88			24,000
		1.3			263,000			6.93			263,000
		1.5			380,000			2.81			380,000
		1.75			1,067			8.84			356
		1.8			190,050			8.48			101,225
		1.85			24,000			8.14			16,000
		1.97			1,422			8.65			593
		Total			1,978,391						1,730,737
	Warrants
	The following table summarizes warrant activity:
			Number of			Weighted
			Warrants			Average
						Exercise
						Price
	Outstanding, June 30, 2014			904,998			1.73
	Granted			-			-
	Exercised			-			-
	Expired			-599,998			1.97
	Outstanding, March 31, 2015			305,000		$	1.26
	Exercisable, June 30, 2014			904,998		$	1.73
	Exercisable, March 31, 2015			305,000		$	1.26
	There was no intrinsic value for all warrants outstanding as of March 31, 2015, based on the fair value of the Company’s common stock on March 31, 2015.
	Additional information regarding warrants outstanding and exercisable as of March 31, 2015 is as follows:
	Warrant Exercise Price			Warrants			Remaining			Warrants Exercisable
				Outstanding			Contractual
							Life (in years)
	$	1.19			150,000			6.73			150,000
		1.25			150,000			0.6			150,000
		3.5			2,500			1.25			2,500
		4			2,500			1.25			2,500
		Total			305,000						305,000
	Restricted Common Stock
	Prior to July 1, 2014, the Company issued 241,968 shares of restricted common stock to employees valued at $417,017, of which $165,401 had been recognized as expense as of June 30, 2014.
	During the nine months ended March 31, 2015, the Company issued 529,393 shares of restricted stock to employees. These shares vest over a three year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met. The aggregate fair value of the stock award was $431,022 based on the market price of our common stock ranging from $0.65 to $1.00 per share on the dates of grant, which will be amortized over the three-year vesting period. All restricted common stock grants are made under the 2007 Equity Compensation Plan.
	The total fair value of all restricted common stock vested during the nine months ended March 31, 2015 was $164,066 and is included in selling, general and administrative expenses in the accompanying statement of operations. As of March 31, 2015, the amount of unvested compensation related to all issuances of restricted common stock was $518,662, which will be recorded as an expense in future periods as the shares vest. When calculating basic net income (loss) per share, these shares are included in weighted average common shares outstanding from the time they vest. When calculating diluted net income per share, these shares are included in weighted average common shares outstanding as of their grant date.
	The following table summarizes restricted common stock activity:
		Number of			Weighted
		Shares			Average
					Grant Date
					Fair Value
Non-vested, June 30, 2014			227,827			1.72
Granted			529,393			0.81
Vested			-106,243			1.81
Forfeited			-			-
Non-vested, March 31, 2015			650,976		$	0.97
Common Stock Repurchase and Retirement
On November 7, 2014 the Company’s Board of Directors authorized the repurchase of up to $250,000 of the Company’s outstanding common stock. During the three months ended March 31, 2015, the Company repurchased 53,300 shares of common stock under the repurchase program at an average price of approximately $0.93 per share for an aggregate amount of approximately $49,482. As of March 31, 2015, $200,518 is remaining under the current authorization to repurchase the Company’s outstanding common stock.
All shares repurchased are retired and deducted from common stock for par value and from additional paid in capital for the excess over par value. Direct costs incurred to acquire the shares are included in the total cost of the shares. Purchases may be made from time to time in open market or privately negotiated transactions as determined by the Company’s management. The actual timing, number and value of shares repurchased will be determined by the Company’s management at its discretion, and will depend on management's evaluation of market conditions and other factors. The Company has no obligation to repurchase any shares under this authorization, and the repurchase program may be suspended, discontinued or modified at any time, for any reason and without notice.

Income_Taxes

Income Taxes	9 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	Note 5. Income Taxes
	For the three months ended March 31, 2015 and 2014, and for the nine months ended March 31, 2014, net losses were $(1,816), $(676,333), and $(1,265,836), respectively, and the Company did not record any provisions for income taxes.
	For the nine months ended March 31, 2015, net income was $1,050,023 and the Company did not record any provision for income taxes primarily because the gain from deconsolidation of our former French subsidiary (discussed further in note 6) was a non-taxable disposition of the Company’s interest in its former French subsidiary.
	In accordance with Accounting Standards Codification (“ASC”) 740, Income Taxes, the Company evaluates its deferred tax assets to determine if a valuation allowance is required based on the consideration of all available evidence using a “more likely than not” standard, with significant weight being given to evidence that can be objectively verified. This assessment considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability; the length of statutory carryover periods for operating losses and tax credit carryovers; and available tax planning alternatives. Our deferred tax assets are composed primarily of U.S. federal net operating loss carryforwards and temporary differences related to stock based compensation. Based on available objective evidence, management believes it is more likely than not that these deferred tax assets are not recognizable and will not be recognizable until its determined that we have sufficient taxable income. We may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. ASC 740 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods, and disclosures. As of March 31, 2015, the Company does not have any liabilities for unrecognized tax uncertainties.

Deconsolidation_of_Former_Fren

Deconsolidation of Former French Subsidiary (TAAG)	9 Months Ended
	Mar. 31, 2015
Discontinued Operations and Disposal Groups [Abstract]
Deconsolidation of Former French Subsidiary (TAAG)	Note 6. Deconsolidation of Former French Subsidiary (TAAG)
	On August 18, 2014 the Board of Directors of the Company authorized management to commit to a plan to sell TAAG. The Company concluded that TAAG’s printing operations in the major geographical area of France were not aligned with the Company’s long term strategy. Accordingly, the operations of TAAG were classified as discontinued operations and comparative information for prior periods has been restated to segregate the assets, liabilities, revenue, expenses, and cash flows related to TAAG as discontinued operations. Further, the Board of Directors of the Company authorized the disposal of TAAG at a reasonable price in relation to its current fair value, and in the event such sale was not consummated by September 10, 2014, that management proceed with an insolvency filing by TAAG under French law. On September 15, 2014, the French Tribunal de Commerce appointed an Administrator for TAAG following a declaration of insolvency by our legal representative, and on October 6, 2014 TAAG entered into a judicial liquidation procedure. As a result, effective September 15, 2014, the Company relinquished control of TAAG to the Tribunal and TAAG ceased to be our subsidiary and was deconsolidated from our financial statements.
	The Company deconsolidated the assets, liabilities and other comprehensive income of TAAG with a resulting non-cash gain on deconsolidation of $1,548,295 recorded on the consolidated statements of operations. The deconsolidation of TAAG will have a material effect on the Company’s revenue as TAAG accounted for 22.1% and 22.6% of consolidated revenue for the years ended June 30, 2014 and 2013, respectively before restatement for discontinued operations.
	The Company has determined based on discussion with French counsel that it is remote that the Company will be generally liable for the unsatisfied liabilities of TAAG as a result of the insolvency process in France. In addition, the Company has also determined based on discussion with French counsel that it is probable that the Company will be liable for specific liabilities associated with TAAG in the amount of $187,907, and as a result, the Company has recorded a liability for that amount as of March 31, 2015.
	The carrying amounts of the major classes of assets and liabilities associated with discontinued operations as of June 30, 2014 were as follows:
	Assets
	Current assets:
	Cash and cash equivalents	$	191,259
	Accounts receivable:
	Trade receivables, net of allowance		746,685
	Due from factor		116,762
	Inventory		192,245
	Prepaid expenses and other current assets		234,232
	Total current assets of discontinued operations		1,481,183
	Other assets:
	Property and equipment, net of accumulated depreciation		418,460
	Deposits and other assets		453,752
	Total non-current assets of discontinued operations		872,212
	Total assets of discontinued operations	$	2,353,395
	Liabilities
	Current liabilities:
	Accounts payable and accrued expenses	$	2,960,378
	Capital lease obligations, current		324,802
	Notes payable, current		11,601
	Deferred revenue		158,359
	Other liability		143,304
	Total current liabilities of discontinued operations		3,598,444
	Long term liabilities:
	Capital lease obligations, long term		113,415
	Total long term liabilities of discontinued operations		113,415
	Total liabilities of discontinued operations	$	3,711,859
	Revenue and expenses from discontinued operations were as follows:
		Three Months Ended				Nine Months Ended
		March 31,				March 31,
		2015		2014		2015		2014
	Revenue	$	-	$	1,850,906	$	1,164,314	$	6,050,428
	Cost of revenue		-		1,192,906		849,174		3,680,299
	Gross profit		-		658,000		315,140		2,370,129
	Operating expenses:
	Selling, general and administrative		-		793,280		660,500		2,367,683
	Depreciation and amortization		-		70,783		44,027		210,777
	Total operating expenses		-		864,063		704,527		2,578,460
	Income (loss) from discontinued operations before other income (expenses)		-		-206,063		-389,387		-208,331
	Other income (expenses):
	Interest expense		-		-10,516		-5,957		-33,097
	Income (loss) from discontinued operations	$	-	$	-216,579	$	-395,344	$	-241,428

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Use of Estimates
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.
	These estimates and assumptions include estimates for reserves of uncollectible accounts, analysis of impairments of recorded goodwill and intangibles, accruals for potential liabilities and assumptions made in valuing equity instruments issued for services or acquisitions.
Concentration of Credit Risk	Concentration of Credit Risk
	Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $250,000 insurance limit. The Company does not anticipate incurring any losses related to these credit risks. The Company extends credit based on an evaluation of the customer's financial condition, generally without collateral. Exposure to losses on receivables is principally dependent on each customer's financial condition. The Company monitors its exposure for credit losses and intends to maintain allowances for anticipated losses, as required.
	Cash denominated in Euros with a US Dollar equivalent of $125,275 and $166,723 at March 31, 2015 and June 30, 2014, respectively, was held by Reprints Desk in accounts at financial institutions located in Europe.
	The following table summarizes revenue concentrations:
		Three Months Ended						Nine Months Ended
		March 31,						March 31,
		2015			2014			2015			2014
	Customer A		*			*			*			13	%
	The following table summarizes vendor concentrations:
		Three Months Ended								Nine Months Ended
		March 31,								March 31,
		2015				2014				2015				2014
	Vendor A		25	%			18	%			19	%			23	%
	Vendor B		10	%			11	%			10	%			11	%
	Vendor C		*				*				*				11	%
	Vendor D		10	%			*				12	%			*
	* Less than 10%
Revenue Recognition	Revenue Recognition
	The Company’s policy is to recognize revenue when services have been performed, risk of loss and title to the product transfers to the customer, the selling price is fixed or determinable, and collectability is reasonably assured. We generate revenue by providing two types of services to our customers: Article Galaxy, and Reprints and ePrints.
	Article Galaxy
	We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. This service, known in the industry as single article delivery or document delivery, generates nearly all of the revenue attributable to the Article Galaxy journal article platform. We recognize revenue from single article delivery services upon delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
	Reprints and ePrints
	We charge a transactional fee for each Reprint or ePrint order and are responsible for printing and delivery of Reprint orders, and the electronic delivery and, in some cases, the electronic delivery mechanism of ePrint orders. The majority of content publishers prints their content in-house and prohibits others from printing their content; however, when not prohibited by the content publisher, we use third parties to print Reprint orders. We recognize revenue from reprints and ePrints services upon shipment or electronic delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
Stock-Based Compensation	Stock-Based Compensation
	The Company periodically issues stock options, warrants and restricted stock to employees and non-employees for services, in capital raising transactions, and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of stock option and warrant awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company estimates the fair value of restricted stock awards to employees and directors using the market price of the Company’s common stock on the date of grant, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company accounts for share-based payments to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates.
Foreign Currency Translation	Foreign Currency
	The accompanying consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the discontinued operations of our former French subsidiary are in Euros, and the costs of Reprints Desk Latin America are in Mexican Pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities.
	Gains and losses from foreign currency transactions, which result from a change in exchange rates between the functional currency and the currency in which a foreign currency transaction is denominated, are included in selling, general and administrative expenses and amounted to $57,647 and $94,118, for the three and nine months ended March 31, 2015, respectively.
	The following table summarizes the exchange rates used:
		Nine Months Ended						Year Ended
		March 31,						June 30,
		2015			2014			2014			2013
	Period end Euro : US Dollar exchange rate		1.09			1.38			1.36			1.3
	Average period Euro : US Dollar exchange rate		1.24			1.35			1.36			1.29
	Period end Mexican Peso : US Dollar exchange rate		0.07			0.08			0.08			0.08
	Average period Mexican Peso : US Dollar exchange rate		0.07			0.08			0.08			0.08
Net Income (Loss) Per Share	Net Income (Loss) Per Share
	Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive. At March 31, 2015 potentially dilutive securities include options to acquire 1,978,391 shares of common stock and warrants to acquire 305,000 shares of common stock.  At March 31, 2014 potentially dilutive securities include options to acquire 1,885,437 shares of common stock and warrants to acquire 904,998 shares of common stock. The dilutive effect of potentially dilutive securities is reflected in diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the reporting period.
	For the nine months ended March 31, 2015, the calculation of diluted earnings per share includes stock options, warrants, and unvested restricted common stock, calculated under the treasury method. Basic and diluted net loss per common share is the same for all periods presented with a net loss because all stock options, warrants, and unvested restricted common stock are anti-dilutive.
	The calculation of basic and diluted net income (loss) per share is presented below:
		Three Months Ended						Nine Months Ended
		March 31,						March 31,
		2015			2014			2015			2014
	Numerator:
	Loss from continuing operations	$	-1,816		$	-459,754		$	-102,928		$	-1,024,408
	Income (loss) from discontinued operations		-			-216,579			1,152,951			-241,428
	Net income (loss)	$	-1,816		$	-676,333		$	1,050,023		$	-1,265,836
	Denominator:
	Weighted average shares outstanding (basic)		17,457,404			17,392,213			17,440,275			17,176,541
	Effect of dilutive unvested restricted common stock		-			-			449,212			-
	Effect of dilutive stock options and warrants		-			-			3,730			-
	Weighted average shares outstanding (diluted)		17,457,404			17,392,213			17,893,217			17,176,541
	Income (loss) per share from continuing operations:
	Basic	$	-		$	-0.03		$	-0.01		$	-0.06
	Diluted	$	-		$	-0.03		$	-0.01		$	-0.06
	Income (loss) per share from discontinued operations:
	Basic	$	-		$	-0.01		$	0.07		$	-0.01
	Diluted	$	-		$	-0.01		$	0.07		$	-0.01
	Net income (loss) per share:
	Basic	$	-		$	-0.04		$	0.06		$	-0.07
	Diluted	$	-		$	-0.04		$	0.06		$	-0.07
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements
	In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. ASU 2014-09 will eliminate transaction- and industry-specific revenue recognition guidance under current U.S. GAAP and replace it with a principle based approach for determining revenue recognition. ASU 2014-09 will require that companies recognize revenue based on the value of transferred goods or services as they occur in the contract. The ASU also will require additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. ASU 2014-09 is effective for reporting periods beginning after December 15, 2016, and early adoption is not permitted. Entities can transition to the standard either retrospectively or as a cumulative-effect adjustment as of the date of adoption. Management is currently assessing the impact the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.
	In August 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued.  An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern.  The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. The Company is currently evaluating the impact the adoption of ASU 2014-15 on the Company’s financial statement presentation and disclosures.
	In January 2015, the FASB issued Accounting Standards Update (ASU) No. 2015-01 (Subtopic 225-20) - Income Statement - Extraordinary and Unusual Items. ASU 2015-01 eliminates the concept of an extraordinary item from GAAP. As a result, an entity will no longer be required to segregate extraordinary items from the results of ordinary operations, to separately present an extraordinary item on its income statement, net of tax, after income from continuing operations or to disclose income taxes and earnings-per-share data applicable to an extraordinary item. However, ASU 2015-01 will still retain the presentation and disclosure guidance for items that are unusual in nature and occur infrequently. ASU 2015-01 is effective for periods beginning after December 15, 2015. The adoption of ASU 2015-01 is not expected to have a material effect on the Company’s consolidated financial statements. Early adoption is permitted.
	In February, 2015, the FASB issued Accounting Standards Update (ASU) No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis. ASU 2015-02 provides guidance on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities such as limited partnerships, limited liability corporations, and securitization structures (collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). ASU 2015-02 is effective for periods beginning after December 15, 2015. The adoption of ASU 2015-02 is not expected to have a material effect on the Company’s consolidated financial statements. Early adoption is permitted.
	In April 2015, the FASB issued an accounting ASU 2015-5,  Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-4)  which provides guidance regarding whether a cloud computing arrangement includes a software license.   If a cloud computing arrangement includes a software license, then the entity should account for the software license element of the arrangement consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the entity should account for the arrangement as a service contract. The guidance will not change GAAP for an entity’s accounting for service contracts. This pronouncement is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2015.  Early adoption is permitted.  The Company is currently evaluating the impact the adoption of ASU 2015-03 on the Company’s financial statements and disclosures.
	Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Schedule of Revenue by Major Customers	The following table summarizes revenue concentrations:
		Three Months Ended						Nine Months Ended
		March 31,						March 31,
		2015			2014			2015			2014
	Customer A		*			*			*			13	%
Schedule of Concentration of Risk	The following table summarizes vendor concentrations:
		Three Months Ended								Nine Months Ended
		March 31,								March 31,
		2015				2014				2015				2014
	Vendor A		25	%			18	%			19	%			23	%
	Vendor B		10	%			11	%			10	%			11	%
	Vendor C		*				*				*				11	%
	Vendor D		10	%			*				12	%			*
	* Less than 10%
Schedule Of Foreign Currency Exchange Rate	The following table summarizes the exchange rates used:
		Nine Months Ended						Year Ended
		March 31,						June 30,
		2015			2014			2014			2013
	Period end Euro : US Dollar exchange rate		1.09			1.38			1.36			1.3
	Average period Euro : US Dollar exchange rate		1.24			1.35			1.36			1.29
	Period end Mexican Peso : US Dollar exchange rate		0.07			0.08			0.08			0.08
	Average period Mexican Peso : US Dollar exchange rate		0.07			0.08			0.08			0.08
Schedule of Earnings Per Share, Basic and Diluted	The calculation of basic and diluted net income (loss) per share is presented below:
		Three Months Ended						Nine Months Ended
		March 31,						March 31,
		2015			2014			2015			2014
	Numerator:
	Loss from continuing operations	$	-1,816		$	-459,754		$	-102,928		$	-1,024,408
	Income (loss) from discontinued operations		-			-216,579			1,152,951			-241,428
	Net income (loss)	$	-1,816		$	-676,333		$	1,050,023		$	-1,265,836
	Denominator:
	Weighted average shares outstanding (basic)		17,457,404			17,392,213			17,440,275			17,176,541
	Effect of dilutive unvested restricted common stock		-			-			449,212			-
	Effect of dilutive stock options and warrants		-			-			3,730			-
	Weighted average shares outstanding (diluted)		17,457,404			17,392,213			17,893,217			17,176,541
	Income (loss) per share from continuing operations:
	Basic	$	-		$	-0.03		$	-0.01		$	-0.06
	Diluted	$	-		$	-0.03		$	-0.01		$	-0.06
	Income (loss) per share from discontinued operations:
	Basic	$	-		$	-0.01		$	0.07		$	-0.01
	Diluted	$	-		$	-0.01		$	0.07		$	-0.01
	Net income (loss) per share:
	Basic	$	-		$	-0.04		$	0.06		$	-0.07
	Diluted	$	-		$	-0.04		$	0.06		$	-0.07

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	9 Months Ended
	Mar. 31, 2015
Stockholders' Equity Note [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes vested and unvested stock option activity:
			All Options						Vested Options					Unvested Options
			Shares			Weighted			Shares			Weighted		Shares		Weighted
						Average						Average				Average
						Exercise						Exercise				Exercise
						Price						Price				Price
	Outstanding at June 30, 2014			1,888,851			1.27			1,526,130			1.21		362,721		1.53
	Granted			89,540			0.82			15,000			0.77		74,540		0.83
	Options vesting			-			-			189,607			1.53		-189,607		1.53
	Exercised			-			-			-			-		-		-
	Forfeited/Cancelled			-			-			-			-		-		-
	Outstanding at March 31, 2015			1,978,391		$	1.25			1,730,737		$	1.24		247,654	$	1.32
Schedule of Share-based Compensation, by Exercise Price Range	Additional information regarding stock options outstanding and exercisable as of March 31, 2015 is as follows:
	Option Exercise Price			Options Outstanding			Remaining			Options Exercisable
							Contractual
							Life (in years)
	$	0.65			6,150			9.61			-
		0.77			59,500			9.39			15,000
		1			370,890			3.89			346,998
		1.02			287,000			5.33			287,000
		1.07			53,898			7.55			50,565
		1.15			278,000			7.86			246,000
		1.2			31,414			9.14			-
		1.25			32,000			7.88			24,000
		1.3			263,000			6.93			263,000
		1.5			380,000			2.81			380,000
		1.75			1,067			8.84			356
		1.8			190,050			8.48			101,225
		1.85			24,000			8.14			16,000
		1.97			1,422			8.65			593
		Total			1,978,391						1,730,737
Schedule Of Share Based Compensation Other Than Options, Activity	The following table summarizes warrant activity:
			Number of			Weighted
			Warrants			Average
						Exercise
						Price
	Outstanding, June 30, 2014			904,998			1.73
	Granted			-			-
	Exercised			-			-
	Expired			-599,998			1.97
	Outstanding, March 31, 2015			305,000		$	1.26
	Exercisable, June 30, 2014			904,998		$	1.73
	Exercisable, March 31, 2015			305,000		$	1.26
Schedule Warrants Outstanding and Exercisable	Additional information regarding warrants outstanding and exercisable as of March 31, 2015 is as follows:
	Warrant Exercise Price			Warrants			Remaining			Warrants Exercisable
				Outstanding			Contractual
							Life (in years)
	$	1.19			150,000			6.73			150,000
		1.25			150,000			0.6			150,000
		3.5			2,500			1.25			2,500
		4			2,500			1.25			2,500
		Total			305,000						305,000
Schedule of Nonvested Restricted Stock Units Activity	The following table summarizes restricted common stock activity:
			Number of			Weighted
			Shares			Average
						Grant Date
						Fair Value
	Non-vested, June 30, 2014			227,827			1.72
	Granted			529,393			0.81
	Vested			-106,243			1.81
	Forfeited			-			-
	Non-vested, March 31, 2015			650,976		$	0.97

Deconsolidation_of_Former_Fren1

Deconsolidation of Former French Subsidiary (TAAG) (Tables)	9 Months Ended
	Mar. 31, 2015
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Disposal Groups Including Discontinued Operations Balance Sheet	The carrying amounts of the major classes of assets and liabilities associated with discontinued operations as of June 30, 2014 were as follows:
	Assets
	Current assets:
	Cash and cash equivalents	$	191,259
	Accounts receivable:
	Trade receivables, net of allowance		746,685
	Due from factor		116,762
	Inventory		192,245
	Prepaid expenses and other current assets		234,232
	Total current assets of discontinued operations		1,481,183
	Other assets:
	Property and equipment, net of accumulated depreciation		418,460
	Deposits and other assets		453,752
	Total non-current assets of discontinued operations		872,212
	Total assets of discontinued operations	$	2,353,395
	Liabilities
	Current liabilities:
	Accounts payable and accrued expenses	$	2,960,378
	Capital lease obligations, current		324,802
	Notes payable, current		11,601
	Deferred revenue		158,359
	Other liability		143,304
	Total current liabilities of discontinued operations		3,598,444
	Long term liabilities:
	Capital lease obligations, long term		113,415
	Total long term liabilities of discontinued operations		113,415
	Total liabilities of discontinued operations	$	3,711,859
Schedule of Disposal Groups Including Discontinued Operations Income Statement	Revenue and expenses from discontinued operations were as follows:
		Three Months Ended				Nine Months Ended
		March 31,				March 31,
		2015		2014		2015		2014
	Revenue	$	-	$	1,850,906	$	1,164,314	$	6,050,428
	Cost of revenue		-		1,192,906		849,174		3,680,299
	Gross profit		-		658,000		315,140		2,370,129
	Operating expenses:
	Selling, general and administrative		-		793,280		660,500		2,367,683
	Depreciation and amortization		-		70,783		44,027		210,777
	Total operating expenses		-		864,063		704,527		2,578,460
	Income (loss) from discontinued operations before other income (expenses)		-		-206,063		-389,387		-208,331
	Other income (expenses):
	Interest expense		-		-10,516		-5,957		-33,097
	Income (loss) from discontinued operations	$	-	$	-216,579	$	-395,344	$	-241,428

Organization_Nature_of_Busines1

Organization, Nature of Business and Basis of Presentation (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Deconsolidation, Gain (Loss), Amount	$0	$0	$1,548,295	$0
Taag [Member]
Deconsolidation, Gain (Loss), Amount			$1,548,295

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details) (Customer A [Member], Customer Concentration Risk [Member])	3 Months Ended				9 Months Ended
	Mar. 31, 2015		Mar. 31, 2014		Mar. 31, 2015		Mar. 31, 2014
Customer A [Member] | Customer Concentration Risk [Member]
Concentration Risk, Percentage		[1]		[1]		[1]	13.00%
[1]	Less than 10%

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Details 1)	3 Months Ended				9 Months Ended
	Mar. 31, 2015		Mar. 31, 2014		Mar. 31, 2015		Mar. 31, 2014
Vendor A [Member]
Concentration Risk, Percentage	25.00%		18.00%		19.00%		23.00%
Vendor B [Member]
Concentration Risk, Percentage	10.00%		11.00%		10.00%		11.00%
Vendor C [Member]
Concentration Risk, Percentage		[1]		[1]		[1]	11.00%
Vendor D [Member]
Concentration Risk, Percentage	10.00%			[1]	12.00%			[1]
[1]	Less than 10%

Summary_of_Significant_Account5

Summary of Significant Accounting Policies (Details 2)	9 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Jun. 30, 2014	Jun. 30, 2013
Euro To US Dollar [Member]
Period end exchange rate	1.09	1.38	1.36	1.3
Average period exchange rate	1.24	1.35	1.36	1.29
Mexian Peso To US Dollar [Member]
Period end exchange rate	0.07	0.08	0.08	0.08
Average period exchange rate	0.07	0.08	0.08	0.08

Summary_of_Significant_Account6

Summary of Significant Accounting Policies (Details 3) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Numerator:
Loss from continuing operations	($1,816)	($459,754)	($102,928)	($1,024,408)
Income (loss) from discontinued operations	0	-216,579	1,152,951	-241,428
Net income (loss)	($1,816)	($676,333)	$1,050,023	($1,265,836)
Denominator:
Weighted average shares outstanding (basic)	17,457,404	17,392,213	17,440,275	17,176,541
Effect of dilutive unvested restricted common stock	0	0	449,212	0
Effect of dilutive stock options and warrants	0	0	3,730	0
Weighted average shares outstanding (diluted)	17,457,404	17,392,213	17,893,217	17,176,541
Income (loss) per share from continuing operations:
Basic	$0	($0.03)	($0.01)	($0.06)
Diluted	$0	($0.03)	($0.01)	($0.06)
Income (loss) per share from discontinued operations:
Basic	$0	($0.01)	$0.07	($0.01)
Diluted	$0	($0.01)	$0.07	($0.01)
Net income (loss) per share:
Basic	$0	($0.04)	$0.06	($0.07)
Diluted	$0	($0.04)	$0.06	($0.07)

Summary_of_Significant_Account7

Summary of Significant Accounting Policies (Details Textual) (USD $)	3 Months Ended	9 Months Ended
	Mar. 31, 2015	Mar. 31, 2015	Mar. 31, 2014	Jun. 30, 2014
Cash, Fdic Insured Amount	$250,000	$250,000
Foreign Currency Transaction Gain (Loss), before Tax	57,647	94,118
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		1,978,391	1,885,437
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		305,000	904,998
Europe Financial Institutions [Member]
Deposits	$125,275	$125,275		$166,723

Line_of_Credit_Details_Textual

Line of Credit (Details Textual) (USD $)	9 Months Ended	1 Months Ended
	Mar. 31, 2015	Jun. 23, 2010	Jun. 30, 2014
Line of Credit Facility, Interest Rate Description	the prime rate plus 5.25%
Line of Credit Facility, Remaining Borrowing Capacity	$2,560,000		$2,185,000
Line of Credit Facility, Interest Rate at Period End	5.75%
Silicon Valley Bank [Member]
Line of Credit Facility, Amount Outstanding		4,000,000
Percentage Of Eligible Accounts Receivable On Line Of Credit		80.00%
Line Of Credit Facility Expiration Date 1	31-Oct-15
Debt Instrument, Basis Spread on Variable Rate	2.50%
Line Of Credit Facility Minimum Amount Outstanding During Period	$800,000
Debt Instrument, Covenant Description	Financial covenants include maintaining a ratio of quick assets to current liabilities of at least 0.8 to 1.0, and maintaining tangible net worth of $500,000, plus 50% of net income for the fiscal quarter ended from and after December 31, 2013, plus 50% of the dollar value of equity issuances after October 1, 2013 (reduced to 40% of the dollar value of equity issuances in connection with the exercise of warrants in November 2013) and the principal amount of subordinated debt.

Stockholders_Equity_Details

Stockholders' Equity (Details) (USD $)	9 Months Ended
	Mar. 31, 2015
Outstanding beginning balance Shares	1,888,851
Granted Shares	89,540
Options vesting Shares	0
Exercised Shares	0
Forfeited/Cancelled Shares	0
Outstanding ending balance Shares	1,978,391
Outstanding beginning balance Weighted Average Exercise Price	$1.27
Granted Weighted Average Exercise Price	$0.82
Options vesting Weighted Average Exercise Price	$0
Exercised Weighted Average Exercise Price	$0
Forfeited/Cancelled Weighted Average Exercise Price	$0
Outstanding ending balance Weighted Average Exercise Price	$1.25
Vested [Member]
Outstanding beginning balance Shares	1,526,130
Granted Shares	15,000
Options vesting Shares	189,607
Exercised Shares	0
Forfeited/Cancelled Shares	0
Outstanding ending balance Shares	1,730,737
Outstanding beginning balance Weighted Average Exercise Price	$1.21
Granted Weighted Average Exercise Price	$0.77
Options vesting Weighted Average Exercise Price	$1.53
Exercised Weighted Average Exercise Price	$0
Forfeited/Cancelled Weighted Average Exercise Price	$0
Outstanding ending balance Weighted Average Exercise Price	$1.24
Unvested [Member]
Outstanding beginning balance Shares	362,721
Granted Shares	74,540
Options vesting Shares	-189,607
Exercised Shares	0
Forfeited/Cancelled Shares	0
Outstanding ending balance Shares	247,654
Outstanding beginning balance Weighted Average Exercise Price	$1.53
Granted Weighted Average Exercise Price	$0.83
Options vesting Weighted Average Exercise Price	$1.53
Exercised Weighted Average Exercise Price	$0
Forfeited/Cancelled Weighted Average Exercise Price	$0
Outstanding ending balance Weighted Average Exercise Price	$1.32

Stockholders_Equity_Details_1

Stockholders' Equity (Details 1) (Stock Options [Member], USD $)	9 Months Ended
	Mar. 31, 2015
Options Outstanding	1,978,391
Options Exercisable	1,730,737
Range One [Member]
Option Exercise Price	$0.65
Options Outstanding	6,150
Options Outstanding Remaining Contractual Life (in years)	9 years 7 months 10 days
Options Exercisable	0
Range Two [Member]
Option Exercise Price	$0.77
Options Outstanding	59,500
Options Outstanding Remaining Contractual Life (in years)	9 years 4 months 20 days
Options Exercisable	15,000
Range Three [Member]
Option Exercise Price	$1
Options Outstanding	370,890
Options Outstanding Remaining Contractual Life (in years)	3 years 10 months 20 days
Options Exercisable	346,998
Range Four [Member]
Option Exercise Price	$1.02
Options Outstanding	287,000
Options Outstanding Remaining Contractual Life (in years)	5 years 3 months 29 days
Options Exercisable	287,000
Range Five [Member]
Option Exercise Price	$1.07
Options Outstanding	53,898
Options Outstanding Remaining Contractual Life (in years)	7 years 6 months 18 days
Options Exercisable	50,565
Range Six [Member]
Option Exercise Price	$1.15
Options Outstanding	278,000
Options Outstanding Remaining Contractual Life (in years)	7 years 10 months 10 days
Options Exercisable	246,000
Range Seven [Member]
Option Exercise Price	$1.20
Options Outstanding	31,414
Options Outstanding Remaining Contractual Life (in years)	9 years 1 month 20 days
Options Exercisable	0
Range Eight [Member]
Option Exercise Price	$1.25
Options Outstanding	32,000
Options Outstanding Remaining Contractual Life (in years)	7 years 10 months 17 days
Options Exercisable	24,000
Range Nine [Member]
Option Exercise Price	$1.30
Options Outstanding	263,000
Options Outstanding Remaining Contractual Life (in years)	6 years 11 months 5 days
Options Exercisable	263,000
Range Ten [Member]
Option Exercise Price	$1.50
Options Outstanding	380,000
Options Outstanding Remaining Contractual Life (in years)	2 years 9 months 22 days
Options Exercisable	380,000
Range Eleven [Member]
Option Exercise Price	$1.75
Options Outstanding	1,067
Options Outstanding Remaining Contractual Life (in years)	8 years 10 months 2 days
Options Exercisable	356
Range Twelve [Member]
Option Exercise Price	$1.80
Options Outstanding	190,050
Options Outstanding Remaining Contractual Life (in years)	8 years 5 months 23 days
Options Exercisable	101,225
Range Thirteen [Member]
Option Exercise Price	$1.85
Options Outstanding	24,000
Options Outstanding Remaining Contractual Life (in years)	8 years 1 month 20 days
Options Exercisable	16,000
Range Fourteen [Member]
Option Exercise Price	$1.97
Options Outstanding	1,422
Options Outstanding Remaining Contractual Life (in years)	8 years 7 months 24 days
Options Exercisable	593

Stockholders_Equity_Details_2

Stockholders' Equity (Details 2) (Warrant [Member], USD $)	9 Months Ended
	Mar. 31, 2015	Jun. 30, 2014
Warrant [Member]
Non-vested, Beginning balance	904,998
Granted Number of Warrants	0
Exercised Number of Warrants	0
Expired Number of Warrants	-599,998
Non-vested, Ending balance	305,000
Exercisable, Number of Warrants	305,000	904,998
Outstanding, Beginning balance Weighted Average Exercise Price	$1.73
Granted Weighted Average Exercise Price	$0
Exercised Weighted Average Exercise Price	$0
Expired Weighted Average Expired Price	$1.97
Outstanding, Ending balance Weighted Average Exercise Price	$1.26
Exercisable, Weighted Average Exercise Price	$1.26	$1.73

Stockholders_Equity_Details_3

Stockholders' Equity (Details 3) (Warrant [Member], USD $)	9 Months Ended
	Mar. 31, 2015
Warrants Outstanding	305,000
Warrants Exercisable	305,000
Range One [Member]
Warrant Exercise Price	$1.19
Warrants Outstanding	150,000
Warrants Outstanding Remaining Contractual Life (in years)	6 years 8 months 23 days
Warrants Exercisable	150,000
Range Two [Member]
Warrant Exercise Price	$1.25
Warrants Outstanding	150,000
Warrants Outstanding Remaining Contractual Life (in years)	7 months 6 days
Warrants Exercisable	150,000
Range Three [Member]
Warrant Exercise Price	$3.50
Warrants Outstanding	2,500
Warrants Outstanding Remaining Contractual Life (in years)	1 year 3 months
Warrants Exercisable	2,500
Range Four [Member]
Warrant Exercise Price	$4
Warrants Outstanding	2,500
Warrants Outstanding Remaining Contractual Life (in years)	1 year 3 months
Warrants Exercisable	2,500

Stockholders_Equity_Details_4

Stockholders' Equity (Details 4) (Restricted Common Stock [Member], USD $)	9 Months Ended
	Mar. 31, 2015
Restricted Common Stock [Member]
Non-vested, Beginning balance	227,827
Granted, Number of Shares	529,393
Vested, Number of Shares	-106,243
Forfeited, Number of Shares	0
Non-vested, Ending balance	650,976
Non-vested, Beginning balance Weighted Average Grant Date Fair Value	$1.72
Granted Weighted Average Grant Date Fair Value	$0.81
Vested Weighted Average Grant Date Fair Value	$1.81
Forfeited Weighted Average Grant Date Fair Value	$0
Non-vested,Ending balance Weighted Average Grant Date Fair Value	$0.97

Stockholders_Equity_Details_Te

Stockholders' Equity (Details Textual) (USD $)	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2015	Jun. 30, 2014	Nov. 07, 2014	Nov. 21, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	2,164,914	2,164,914
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2		5 years 10 months 24 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term		6 years
Fair value of vested stock options		$163,702
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	201,912	201,912
Stock Issued During Period, Value, Restricted Stock Award, Gross		164,336
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	60,745	60,745
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	43,140	43,140
Stock Repurchase Program, Authorized Amount				250,000
Stock Repurchased During Period, Shares	53,300
Stock Repurchased During Period, Value	49,482	50,605
Stock Repurchase Program, Remaining Authorized Repurchase Amount	200,518	200,518
Shares Repurchased, Price Per Share	$0.93	$0.93
Restricted Common Stock [Member]
Fair value of vested stock options		164,066
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	518,662	518,662
Stock Issued During Period, Value, Restricted Stock Award, Gross		431,022	417,017
Stock Issued During Period, Shares, Restricted Stock Award, Gross		529,393	241,968
Allocated Share-based Compensation Expense			$165,401
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant					3,000,000
Minimum [Member] | Restricted Common Stock [Member]
Common Stock Market Price Per Share	$0.65	$0.65
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant					5,000,000
Maximum [Member] | Restricted Common Stock [Member]
Common Stock Market Price Per Share	$1	$1

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Net Income (Loss) Attributable to Parent	($1,816)	($676,333)	$1,050,023	($1,265,836)

Deconsolidation_of_Former_Fren2

Deconsolidation of Former French Subsidiary (TAAG) (Details) (USD $)	Mar. 31, 2015	Jun. 30, 2014
Current assets:
Cash and cash equivalents		$191,259
Accounts receivable:
Trade receivables, net of allowance		746,685
Due from factor		116,762
Inventory		192,245
Prepaid expenses and other current assets		234,232
Total current assets of discontinued operations	0	1,481,183
Other assets:
Property and equipment, net of accumulated depreciation		418,460
Deposits and other assets		453,752
Total non-current assets of discontinued operations	0	872,212
Total assets of discontinued operations		2,353,395
Current liabilities:
Accounts payable and accrued expenses		2,960,378
Capital lease obligations, current		324,802
Notes payable, current		11,601
Deferred revenue		158,359
Other liability		143,304
Total current liabilities of discontinued operations	0	3,598,444
Long term liabilities:
Capital lease obligations, long term		113,415
Total long term liabilities of discontinued operations	0	113,415
Total liabilities of discontinued operations		$3,711,859

Deconsolidation_of_Former_Fren3

Deconsolidation of Former French Subsidiary (TAAG) (Details 1) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Revenue	$0	$1,850,906	$1,164,314	$6,050,428
Cost of revenue	0	1,192,906	849,174	3,680,299
Gross profit	0	658,000	315,140	2,370,129
Operating expenses:
Selling, general and administrative	0	793,280	660,500	2,367,683
Depreciation and amortization	0	70,783	44,027	210,777
Total operating expenses	0	864,063	704,527	2,578,460
Income (loss) from discontinued operations before other income (expenses)	0	-206,063	-389,387	-208,331
Other income (expenses):
Interest expense	0	-10,516	-5,957	-33,097
Income (loss) from discontinued operations	$0	($216,579)	($395,344)	($241,428)

Deconsolidation_of_Former_Fren4

Deconsolidation of Former French Subsidiary (TAAG) (Details Textual) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014	Jun. 30, 2014	Jun. 30, 2013
Deconsolidation, Gain (Loss), Amount	$0	$0	$1,548,295	$0
Reserve For Deconsolidation Liability	187,907		187,907
Sales Revenue, Net [Member]
TAAG revenue percentage					22.10%	22.60%
Taag [Member]
Deconsolidation, Gain (Loss), Amount			$1,548,295